Effects of fibroblast growth factor 2 on osteoblastic proliferation and differentiation by regulating bone morphogenetic protein receptor expression

Journal of Craniofacial Surgery

Volumn 22, Issue 5, 2011, Pages 1880-1882

  Park, Jun Beom ^a  

^a Seoul National University   (South Korea)

Author keywords

Differentiation; Fibroblast growth factor; Osteoblast; Proliferation

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR; FIBROBLAST GROWTH FACTOR 2;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; MOUSE; OSTEOBLAST; PHYSIOLOGY; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN RECEPTORS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; MICE; OSTEOBLASTS;

EID: 80053510740     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e31822e8434     Document Type: Article

References (13)

1. Mansukhani A, Bellosta P, Sahni M, et al. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol 2000;149: 1297-1308 (Pubitemid 30399682)
2. Moursi AM, Winnard PL, Winnard AV, et al. Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion. Cleft Palate Craniofac J 2002;39:487-496 (Pubitemid 34977584)
3. Xiao G, Jiang D, Gopalakrishnan R, et al. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 2002;277:36181-36187
4. Sobue T, Naganawa T, Xiao L, et al. Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice. J Cell Biochem 2005;95:83-94 (Pubitemid 41420218)
5. Park SJ, Kim SH, Choi HS, et al. Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling. Bone 2009;45:994-1003
6. Debiais F, Hott M, Graulet AM, et al. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res 1998;13: 645-654 (Pubitemid 28163015)
7. Shea LD, Wang D, Franceschi RT, et al. Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng 2000;6:605-617
8. Saadeh PB, Mehrara BJ, Steinbrech DS, et al. Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells. Endocrinology 2000;141:2075-2083 (Pubitemid 32274359)
9. Pinzone JJ, Stevenson H, Strobl JS, et al. Molecular and cellular determinants of estrogen receptor alpha expression. Mol Cell Biol 2004;24:4605-4612 (Pubitemid 38668029)
10. Imai Y, Youn MY, Kondoh S, et al. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. Ann N Y Acad Sci 2009;1173:E31-E39
11. Compston JE. Sex steroids and bone. Physiol Rev 2001;81:419-447 (Pubitemid 32096180)
12. HuangW, Carlsen B, Rudkin G, et al. Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells. Bone 2004;34:799-808 (Pubitemid 38581125)
13. Leali D, Dell'Era P, Stabile H, et al. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J Immunol 2003;171: 1085-1093 (Pubitemid 36871426)